SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers · Study

ArticleShelves

ArticlePsilocybin dose-dependently causes delayed, transient headaches in healthy volunteers

Matthew W. Johnson2011

OA

Articlegreen2011

Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers

Matthew W. Johnson · Richard Andrew Sewell · Roland R. Griffiths

127 citations·0/0 files stored·Drug and Alcohol Dependence

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Psychedelics and Drug Studies Migraine and Headache Studies Hallucinations in medical conditions

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 127 citations exist upstream.

References

2006Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance 1998The Psychology of Religion: An Empirical Approach 2004Hallucinogens 2008Human hallucinogen research: guidelines for safety 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action 1986The Psychology of Religion: An Empirical Approach 2011Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects 2008Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

Cited by

2019Psychedelic microdosing benefits and challenges: an empirical codebook 2014Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes 2024Acute Adverse Effects of Therapeutic Doses of Psilocybin 2020A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses 2012High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2013Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimolreview · 13 shared references 2013Psilocybin – Summary of knowledge and new perspectivesreview · 12 shared references 2016Phenomenology, Structure, and Dynamic of Psychedelic Stateschapter · 10 shared references 2017Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiencesarticle · 10 shared references 2021Dose–response relationships of psilocybin-induced subjective experiences in humansreview · 10 shared references 2020Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Reviewreview · 10 shared references

Details

Year2011

Typearticle

Published2011-12-06

VenueDrug and Alcohol Dependence

ISSN-L0376-8716

Languageen

Citations127

Files0 public / 0

ShelfPsychedelics and Drug Studies

Identifiers

doi10.1016/j.drugalcdep.2011.10.029

openalex_workW2022443784

Links

Imported from OpenAlex (CC0) — nothing here is generated.

2022Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research

2014Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases

2013Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol